quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:06:56·27d
SECFiling
Senti Biosciences Inc. logo

SEC Form 10-K filed by Senti Biosciences Inc.

SNTI· Senti Biosciences Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • SNTI
    Senti Biosciences Inc.
    Health Care

Recent analyst ratings

  • Oct 14UpdateH.C. Wainwright$12.00
  • Jun 6UpdateLaidlaw$5.00
  • Oct 7UpdateMorgan Stanley$7.50

Related

  • SEC7d
    Amendment: SEC Form SCHEDULE 13D/A filed by Senti Biosciences Inc.
  • PR10d
    Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
  • SEC22d
    Senti Biosciences Inc. filed SEC Form 8-K: Other Events
  • PR22d
    Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
  • SEC23d
    Amendment: SEC Form SCHEDULE 13D/A filed by Senti Biosciences Inc.
  • SEC27d
    Senti Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR27d
    Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
  • PR31d
    Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022